Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.

Atherosclerosis. Supplements - 1 Nov 2017

Stefanutti Claudia, Mazza Fabio, Mesce Dario, Morozzi Claudia, Di Giacomo Serafina, Vitale Marco, Pergolini Mario

Abstract excerpt

BACKGROUND: Hypercholesterolaemia is a major risk factor for cardiovascular disease and requires effective therapy in affected patients. Statins, the mainstay of lipid-lowering therapy, can cause side effects, including myalgia, in some patients. Ezetimibe, is frequently used as an add-on therapy for statins, and is also used as a monotherapy in statin-intolerant patients, however elevations in liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, Dietary
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diet, Fat-Restricted

Share to Dietary Supplements

Share to Ezetimibe

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipoproteinemia Type II

Share to Lovastatin

Source

Identifiers

PMID: 29096866
DOI: 10.1016/j.atherosclerosissup.2017.05.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.PMID 29096866Read ↗

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemiaSemantic proximity Read ↗

Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.Semantic proximity Read ↗

Semisynthesis of novel monacolin J derivatives: hypocholesterolemic and neuroprotective activities.Semantic proximity Read ↗

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.Semantic proximity Read ↗

Intolerance to statins: mechanisms and management.Semantic proximity Read ↗

Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemia.Semantic proximity Read ↗

Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity With Lomitapide Mesylate and Mipomersen in Patients With Homozygous Familial Hypercholesterolemia.Semantic proximity Read ↗

Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but….Semantic proximity Read ↗

Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects.Semantic proximity Read ↗

Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.Semantic proximity Read ↗

Statin induced myotoxicity.Semantic proximity Read ↗

Non-cardiovascular effects associated with statins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.